Haoxi Health Technology Ltd
7 hedge funds and large institutions have $499K invested in Haoxi Health Technology Ltd in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
101% more capital invested
Capital invested by funds: $248K → $499K (+$251K)
9.16% more ownership
Funds ownership: 0.32% → 9.48% (+9.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$1.88M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.18M |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$940K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$235K |
| 5 |
HF
HRT Financial
New York
|
+$235K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$65.6K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$55.2K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6K |
| 4 |
Morgan Stanley
New York
|
-$27 |
HAO Hedge Fund Activity: Q3 2024 in Review
7 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Haoxi Health Technology Ltd (HAO) for Q3 2024, worth a combined $499K — up 101% from $248K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new HAO positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Meteora Capital, opening a new position worth an estimated $1.88M. The largest seller was Invesco, cutting an estimated $65.6K.
- 7 institutional investors held Haoxi Health Technology Ltd (HAO) as of Q3 2024, up from 0 in Q2 2024.
- Funds reported $499K of Haoxi Health Technology Ltd stock for Q3 2024, up 101% quarter-over-quarter.
- 7 funds opened new Haoxi Health Technology Ltd positions in Q3 2024 and 0 closed out, a net change of +7 holders.
- The largest Haoxi Health Technology Ltd buyer in Q3 2024 was Meteora Capital, an estimated $1.88M added.
- The largest Haoxi Health Technology Ltd seller in Q3 2024 was Invesco, an estimated $65.6K sold.
Based on aggregated 13F filings for Q3 2024.